These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8198867)

  • 41. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.
    Tary-Lehmann M; Lehmann PV; Schols D; Roncarolo MG; Saxon A
    J Exp Med; 1994 Nov; 180(5):1817-27. PubMed ID: 7964463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe combined immunodeficient mice engrafted with macaque peripheral blood leukocytes support replication of SIVsmm.
    Schwiebert RS; Fultz PN
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):269-74. PubMed ID: 9491918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
    Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
    Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell engraftment in lymphoid tissues of human peripheral blood lymphocyte reconstituted SCID mice with or without prior activation of cells.
    Olive C; Cheung C; Falk MC
    Immunol Cell Biol; 1998 Dec; 76(6):520-5. PubMed ID: 9893029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.
    Hoffmann-Fezer G; Gall C; Zengerle U; Kranz B; Thierfelder S
    Blood; 1993 Jun; 81(12):3440-8. PubMed ID: 8099506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
    Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
    J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
    Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SCID mouse as a model for transplantation studies.
    Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
    J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin.
    Delhem N; Hadida F; Gorochov G; Carpentier F; de Cavel JP; Andréani JF; Autran B; Cesbron JY
    J Immunol; 1998 Aug; 161(4):2060-9. PubMed ID: 9712080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.
    Krowka JF; Sarin S; Namikawa R; McCune JM; Kaneshima H
    J Immunol; 1991 Jun; 146(11):3751-6. PubMed ID: 1827814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
    Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
    Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin.
    Nicoletti F; Lapenta C; Donati S; Spada M; Ranazzi A; Cacopardo B; Mangano K; Belardelli F; Perno C; Aquaro S
    Clin Exp Immunol; 2009 Jan; 155(1):28-34. PubMed ID: 19076826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
    Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct rate and patterns of human CD4+ T-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus.
    Mosier DE
    J Clin Immunol; 1995 Nov; 15(6 Suppl):130S-133S. PubMed ID: 8613486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.
    Honeycutt JB; Wahl A; Archin N; Choudhary S; Margolis D; Garcia JV
    Retrovirology; 2013 Oct; 10():121. PubMed ID: 24156277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera.
    Segall H; Lubin I; Marcus H; Canaan A; Reisner Y
    Blood; 1996 Jul; 88(2):721-30. PubMed ID: 8695821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
    Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
    Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.
    Safrit JT; Fung MS; Andrews CA; Braun DG; Sun WN; Chang TW; Koup RA
    AIDS; 1993 Jan; 7(1):15-21. PubMed ID: 7680205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288.
    Agatsuma T; Abe K; Furukawa H; Koga R; Koizumi M; Hotoda H; Kaneko M
    Antiviral Res; 1997 May; 34(3):121-30. PubMed ID: 9191019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.